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Workshop Innovations in Imaging for
Comprehensive Assessment of Musculoskeletal
Disorders*After 35 years of holding this workshop (see article by Harry
K. Genant in this issue), the upcoming 20th International
Bone Densitometry Workshop (IBDW) in Hong Kong may well
represent an important turning point in its long and
impressive history. The subtitle chosen by the organizers of
this meeting, Professor Ling Qin and his team, indicates the
expanded aims of the workshop: “Advanced Musculoskel-
etal Biomedical Imaging Workshop: from technology to
application e molecular / cellular / structural /
functional imaging”.
The IBDW has always focused on imaging technology
development with the aim to critically evaluate the
strengths and limitations of new imaging methods for
improved assessment of skeletal disorders, most notably
osteoporosis. The combination of technical experts with
the presence of experienced clinicians provided a sound
basis for determining which of the many exciting technol-
ogies and image processing approaches would be most
suited for improved assessment of bone strength and frac-
ture risk. However, the field in which we work has diversi-
fied and changed and of course there is a need, not only to
keep up with these changes, but to stay ahead and provide
stimuli and guidance for renewing the methodological
armamentarium. The following challenges can be noted:
(1) expanding the assessment of osteoporosis to a
broader variety of skeletal disorders
(2) additional assessment of non-mineralized compo-
nents of bone tissue
(3) the evaluation of muscular disorders, including the
interaction of muscle and bone* On behalf of the International and Local Organizing Committee
of the 20th IBDW (http://ibdw2014hongkong.org/).
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(4) hierarchical imaging from the organ and tissue level
down to cellular and molecular imaging, i.e., linking
whole body imaging with microscopic techniques
(5) complementing morphological imaging by functional
imaging, with regard to both biomechanical and
pathophysiological function
(6) linking clinical and preclinical imaging with the ulti-
mate goal of translation.
In previous IBDWs, preclinical techniques and appli-
cations in areas beyond osteoporosis have been covered
to some extent, e.g., for the assessment of body
composition. However, we can congratulate the current
IBDW president and his team for putting together a much
more ambitious program, meeting the demands noted
above. As we glance through the program we have ses-
sions on:
(1) preclinical imaging of bone, cartilage, and muscle
with applications in bone regeneration and therapy of
musculoskeletal disorders
(2) clinical imaging of bone featuring quantitative
computed tomography (QCT) topics including high
resolution imaging, dual use computed tomography
(CT), and finite element (FE) modelling, plus new de-
velopments around dual energy X-ray absorptiometry
(DXA), specifically the trabecular bone score and the
definition of osteoporotic fracture
(3) molecular, cellular, and functional imaging, focusing
on micro imaging of osteocytes, stem cells in the
process of skeletal repair, high throughput imaging,
and optical imaging
(4) clinical rheumatoid imaging of rheumatoid arthritis,
osteoarthritis, and disk degeneration
(5) special topics in paediatric musculoskeletal imagingore) Pte Ltd. This is an open access article under the CC BY-NC-ND
186 Foreword(6) imaging of muscle and fat, cartilage, and the vascular
system
(7) quantitative imaging of mechanical competence
using CT and ultrasound
(8) oncologic and orthopaedic imaging of skeletal tissue.
So indeed the whole range of imaging bone, muscle, fat,
cartilage, and the related vasculature will be covered from
the cell to clinical application, with applications to major
diseases like osteoporosis, rheumatic diseases, and cancer.
Without any doubt, attending the workshop will be
stimulating. This is important, because we have exciting
opportunities for progress. I believe the following areas are
particularly relevant and progress would be particularly
needed and important:
(1) Bringing QCT to the clinic. After many years of tak-
ing a backseat position, QCT has recently seen a lot of
progress in technology and important studies have
been conducted documenting the advantage of QCT
over DXA in a number of aspects, but also lacking
important aspects (e.g., superiority in hip fracture
prediction). However, this has not yet led to a more
widespread use of QCT. Issues like standardization,
reference data, widespread access to standard soft-
ware, and radiation exposure play a role. Hopefully,
we will generate some momentum at this meeting.
(2) Development of surrogate markers of bone fragility.
Finite element is a powerful tool that may one day be
accepted as a surrogate marker of fragility, i.e., be
accepted as an endpoint in clinical drug studies that
currently rely on fracture incidence (and huge patient
numbers). However, the issues regarding QCT previ-
ously states need to be resolved. Moreover, it remains
to be proven, that FE based estimates of strength
reflect fracture risk even during treatment, and for
treatments that work through very different
mechanisms.
(3) Translating innovations in molecular imaging into
human application. Preclinical imaging is very
powerful but because of limited penetration depth,
radiation dose, and other aspects, one typically has
to rely on different modalities when imaging pa-
tients. How such transitions can be achieved remains
a big challenge and requires specific solutions for
each disease area.
(4) Develop imaging companion diagnostics suited for
personalized medicine. Personalized medicine is
seen as a solution for the future for many diseaseareas, acknowledging the differences in disease sub-
types for individual patients. This concept needs to
be addressed also for musculoskeletal disorders.
Some aspects are already obvious, e.g., bone fragility
and muscular frailty may both lead to fracture, but
causal treatments will differ, requiring appropriate
differential diagnostic assessment. However much
greater refinement is needed and for each subtype of
disease and for each specific cause of disease, one
needs diagnostic clarification in patients to optimize
their personalized treatment; imaging should have a
lead role here. Thus, we need to pair diagnostic
procedure and treatment options and not restrict
companion diagnostics to gene tests and laboratory
assessments.The week ahead
Standard meetings, and the musculoskeletal field makes no
exception in this regard, have only a limited focus on the
imaging technologies, and the value of science and engi-
neering of method development is not regularly appreci-
ated. Clinicians and basic researchers alike are very
thankful if they can apply the latest diagnostic technolo-
gies, but they rarely understand the difficulties and lengthy
processes required to reach that stage. In meetings like the
IBDW, imaging experts meet imaging experts and this has
always been a fruitful and most rewarding exercise. I am
absolutely convinced that we have an exciting, thought
provoking, and insightful week on interdisciplinary high
tech imaging and image processing ahead of us, thanks to
the organizers, the speakers, and all participants.
Claus-C. Glu¨er*
Professor of Medical Physics, Sektion Biomedizinische
Bildgebung, Klinik fu¨r Radiologie und Neuroradiologie,
Universita¨tsklinikum Schleswig-Holstein,
Christian-Albrechts-Universita¨t zu Kiel, Kiel, Germany
*Sektion Biomedizinische Bildgebung,
Klinik fu¨r Radiologie und Neuroradiologie,
UKSH, Christian-Albrechts-Universita¨t zu Kiel, MOIN CC,
Am Botanischen Garten 14, 24118 Kiel, Germany.
E-mail address: glueer@rad.uni-kiel.de
15 July 2014
Available online 23 August 2014
